APOLIPOPROTEIN-E POLYMORPHISM AND CORONARY-ARTERY DISEASE
APOLIPOPROTEIN-E POLYMORPHISM AND CORONARY-ARTERY DISEASE
复制标题
DOI:
10.1161/01.atv.3.4.310
复制
发表时间:
1983-01-01
期刊:
影响因子:
--
通讯作者:
ASSMANN, G
中科院分区:
文献类型:
--
作者:
MENZEL, HJ;KLADETZKY, RG;ASSMANN, G
Lipid status and apolipoprotein E phenotypes were tested in 1000 patients who underwent coronary angiography. The same number of factory employees was chosen as a control group. Six different apolipoprotein E phenotypes were distinguished and their frequencies in all groups were determined. For the 3 homozygous phenotypes, E3/3, E4/4 and E2/2, the percentage distribution in the group of factory employees was 62.7, 2.3 and 0.8%, respectively; for the 3 heterozygous phenotypes, E4/3, E3/2 and E4/2, frequencies of 20.3, 11.0 and 3.0% were determined. In the group of patients with and without signs of coronary arterosclerosis almost the same frequencies were observed except that heterozygous (E3/2) occurred significantly more frequently in the group of coronary angiography patients unaffected by coronary sclerosis. Cholesterol and triglyceride values were significantly elevated in patients with coronary artery disease, whereas high density lipoprotein cholesterol levels were not significantly different. Apparently, apolipoprotein E2/2 homozygosity, despite the presence of .beta.-very low density lipoproteins in the plasma of these patients, cannot be considered a biochemical indicator of an increased risk of coronary atherosclerosis. On the other hand, apolipoprotein E3/2 heterozygosity may have a protective effect on the development of early atherosclerosis.